A Trial of Dyanavel XR in Treating Co-occurring Fatigue Symptoms in Adults With Attention Deficit Hyperactivity Disorder (ADHD).

NCT06248229 PHASE4 RECRUITING

The goal of this clinical trial is to study the impact of Dyanavel on co-occuring fatigue in adults with Attention Deficit/Hyperactivity Disorder. The main question it aims to answer is whether Dyanavel XR leads to a statistically significant reduction in fatigue compared to placebo, as measured by the Fatigue Symptom Inventory.

Details

Lead sponsor	Rochester Center for Behavioral Medicine
Phase	PHASE4
Status	RECRUITING
Enrolment	50
Start date	Sun Sep 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Tue Dec 01 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Fatigue
• Attention Deficit Hyperactivity Disorder
• Attention Deficit Disorder

Interventions

• Dyanavel XR
• Placebo

Countries

United States